Local Coverage
KESIMPTA® (ofatumumab) coverage is better than ever!
![[9 out of 10] patients with commercial insurance are covered, with [>80%] having first-line coverage. [$0] No out-of-pocket costs reported in [97%] of claims for commercially insured patients using the [$0] copay card. Patients don't wait weeks—start today with samples.](https://usim.beprod.kesimptahcp.com/sites/kesimptahcp_com/files/styles/webp/public/styles/common_width_472/public/2025-06/4.2-alongside-kes-delivers-large-numbers-mobile_0.png.webp?itok=M62FDpsa)
*Based on Managed Markets Insight & Technology, LLC database as of May 2024.1
†Limitations apply. Offer not valid under Medicare, Medicaid, or any other federal or state health insurance program. Patients with commercial insurance who are initially denied coverage may receive free KESIMPTA for up to 12 months while seeking coverage. Patients with commercial insurance who have coverage for KESIMPTA may receive up to $18,000 in annual copay benefits. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions at start.kesimpta.com.
‡Sample program is only available to patients who are determined to be appropriate candidates for treatment with KESIMPTA and is intended to give patients a chance to see if KESIMPTA may be right for them.
Find Coverage
Explore coverage in your area with the interactive tool below
Alongside KESIMPTA
Alongside™ KESIMPTA aims to deliver seamless onboarding
Support for your office
Dedicated Access Reimbursement Manager
- Helps navigate the prior authorization and appeals process
- Troubleshoots any coverage or reimbursement issues
Support for your patients
We'll automatically enroll your patients in Alongside KESIMPTA for support and assistance throughout their first year on treatment. Dedicated Coordinators tailor support so patients are prepared, not overwhelmed.
![Patient Access [Coordinator]](https://usim.beprod.kesimptahcp.com/sites/kesimptahcp_com/files/styles/webp/public/styles/common_width_400/public/2024-09/alongsidekesimpta_people_pac_rgb_100x100.png.webp?itok=wM1A_LVx)
Patient Access Coordinator
- Completes benefits verification
- Informs the patient of coverage status and next steps
![Two dedicated [coordinators]](https://usim.beprod.kesimptahcp.com/sites/kesimptahcp_com/files/styles/webp/public/styles/common_width_400/public/2024-09/alongsidekesimpta_people_carepartner_rgb_100x100.png.webp?itok=UL5BsIa7)
Dedicated Coordinator
- Performs supplemental injection training
- Provides 1-on-1 tailored support for up to 2 years
Helpful Templates
Templates to help navigate insurance coverage
Looking for Prior Authorization forms? Visit the Getting Started page.
Download Sample Letter of Appeal—New Treatment
Download Sample Letter of Appeal—Change to Treatment
Download Sample Letter of Medical Necessity—New Treatment
Download Sample Letter of Medical Necessity—Change of Treatment
Contact your Sales Representative for a Sensoready® Demo Pen
References: 1. Data on file. Coverage Change-ESI. Novartis Pharmaceuticals Corp; East Hanover, NJ. May 2024. 2. Data on file. First-line commercial coverage. Novartis Pharmaceuticals Corp; East Hanover, NJ. October 2024. 3. Data on file. 97 percent OOP. Novartis Pharmaceuticals Corp; East Hanover, NJ. July 2024.